ClinicalTrials.Veeva

Menu

Opioid Maintenance Medications Comparison Study

Johns Hopkins University logo

Johns Hopkins University

Status and phase

Completed
Phase 2

Conditions

Opioid Dependence

Treatments

Drug: LAAM. buprenorphine and methadone

Study type

Interventional

Funder types

Other

Identifiers

NCT00344812
BPR-95-07-24-03

Details and patient eligibility

About

A 17 week, double-blind, randomized, parallel group, four arm design outpatient study comparing LAAM, buprenorphine and two dose levels of methadone for the treatment of opioid dependence.

Sex

All

Ages

21 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion

  • age 21 to 55 years
  • diagnosis of opioid dependence by criteria of the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV)
  • evidence of recent opioid use on toxicologic screening

Exclusion

  • serious medical or psychiatric illness requiring long-term medication
  • positive pregnancy test

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems